USPTO serial 88907223
PYLON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 26, 2022
- Examiner
- BURDECKI, ANNA C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PYLON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew T. Pettit
Andrew T. Pettit PERKINS COIE LLP3150 PORTER DRIVEPALO ALTO, CA 94304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for reacting with biomolecules for scientific use; reagents for scientific use; reagents for reacting with biomolecules for research use; reagents for research use; diagnostic reagents for scientific research use; diagnostic reagents, buffers, and preparations, except for medical and veterinary use; biochemical reagents used for non-medical purposes for detecting and/or analyzing antigens, antibodies, proteins, ligands, or nucleotides; laboratory chemicals, namely, antibody reagents used for the detection of antigens or antibodies in liquid, cell, and tissue analysis for in vitro diagnostic use; diagnostic preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations other than for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes | ACTIVE | — |
| 005 | Reagents for reacting with biomolecules for medical use; reagents for medical use; diagnostic reagents for medical use; diagnostic reagents, buffers, and preparations for medical use; biochemical reagents used for medical purposes for detecting and/or analyzing antigens, antibodies, proteins, ligands, or nucleotides; chemicals, namely, antibody reagents used for the detection of antigens or antibodies in liquid, cell, and tissue analysis for in vitro diagnostic use for medical purposes; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations for medical or veterinary purposes, namely, reagents, buffers, and preparations for modifying a probe to which biomolecules bind for diagnostic purposes | ACTIVE | — |
| 009 | Laboratory apparatus, namely, immunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample through interferometry; laboratory apparatus, namely, immunoassay analyzers for studying biomolecules in blood, serum, or plasma samples through interferometry; interferometric laboratory apparatus, namely, automated immunoassay analyzers for scientific, research, or diagnostic use, not for medical purposes; interferometric laboratory apparatus, namely, immunochemistry analyzers for performing immunoassays on body fluids; automated research laboratory analyzer for clinical chemistry applications in the nature of measuring, testing and analyzing blood and other bodily fluids through interferometry; laboratory instruments for analyzing biomolecules at different stages of therapeutic development through interferometry; interferometric instruments being interferometers for use in scientific, research, or diagnostic procedures, not for medical purposes; laboratory imaging instruments for studying biomolecules in the nature of proteins, ligands, and nucleic acids through interferometry, for research purposes; automated medical laboratory analyzer for detecting the presence or concentration of biomolecules through interferometry | ACTIVE | — |
| 010 | Medical diagnostic apparatus, namely, immunoassay analyzers for analyzing body fluids through the measuring of light interference; medical diagnostic apparatus, namely, immunoassay analyzers for studying biomolecules in blood, serum, or plasma samples for medical purposes; medical diagnostic apparatus, namely, automated immunoassay analyzers for medical use; medical diagnostic apparatus, namely, immunochemistry analyzers for performing immunoassays on body fluids; interferometric instruments in the nature of interferometers for medical purposes, for use in medical procedures; medical diagnostic imaging instruments for studying biomolecules, including proteins, ligands, and nucleic acids, for medical purposes; medical diagnostic instruments for analyzing body fluids through interferometry; medical diagnostic tool for investigating scientific questions and conducting tests for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Access Medical Systems
- Other trademarks owned by Access Medical Systems
- Other trademarks owned by Access Medical Systems
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named PYLON
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 22, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 21, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2022 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 14, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 13, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 3, 2021 | IUAF | USE AMENDMENT FILED | — |
| Dec 3, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 3, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 3, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 8, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 13, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 13, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 10, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 10, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 12, 2020 | NWAP | NEW APPLICATION ENTERED | — |